Ulrika Maria Wennberg
Comptroller/Controller/Auditor chez Huge Fastigheter AB
Profil
Ulrika Maria Wennberg is currently working as an Accountant at SRV Återvinning AB, Södertörns Energi AB, Södertörns Fjärrvärme AB, Huge Fastigheter AB, Söderenergi Kraftvärme AB, and Södertörns Utvecklingscentrum.
Previously, she worked as the Chief Executive Officer at Axelar AB, Chief Executive Officer & Chief Financial Officer at Jederstrom Pharmaceuticals AB, Director at DermaGen AB and Pergamum AB, and Chief Operating Officer at Promore Pharma AB and PharmaSurgics In Sweden AB.
Ms. Wennberg completed her undergraduate degree from the University of Lund.
Postes actifs de Ulrika Maria Wennberg
| Sociétés | Poste | Début |
|---|---|---|
| Huge Fastigheter AB | Comptroller/Controller/Auditor | - |
Södertörns Utvecklingscentrum
 Södertörns Utvecklingscentrum Miscellaneous Commercial ServicesCommercial Services Södertörns Utvecklingscentrum is a private company based in Huddinge, Sweden. The Swedish company provides professional services. | Comptroller/Controller/Auditor | - |
| Söderenergi Kraftvärme AB | Comptroller/Controller/Auditor | - |
SRV Återvinning AB
 SRV Återvinning AB SemiconductorsElectronic Technology SRV Återvinning AB is a private company based in Huddinge, SE. SRV Återvinning AB manufactures renewable energy semiconductor products. The Swedish company was founded in 1949. Mette Holst has been the CEO of the company since 2018. | Comptroller/Controller/Auditor | - |
| Södertörns Fjärrvärme AB | Comptroller/Controller/Auditor | - |
| Södertörns Energi AB | Comptroller/Controller/Auditor | - |
Anciens postes connus de Ulrika Maria Wennberg
| Sociétés | Poste | Fin |
|---|---|---|
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Directeur des opérations | 01/01/2020 |
Axelar AB
 Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Directeur Général | 20/06/2018 |
Jederstrom Pharmaceuticals AB
 Jederstrom Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Jederstrom Pharmaceuticals is a life sciences company that is developing new formulations for oral delivery of therapeutic proteins. These new formulations offer new and improved therapeutic possibilities, cost advantages and the convenience factor of oral administration. The vision of Jederstrom Pharmaceuticals is to make oral administration the method of choice for a number of key therapeutic proteins. Jederstrom Pharmaceuticals initial focus is to develop an insulin formulation for oral administration. Formulations of other well-known therapeutic proteins will then be developed. Jederstrom Pharmaceuticals' business model shall be out licensing. Jederstrom Pharmaceuticals was founded in 2001 by Gustaf Jederström, inventor of the formulation technology. Gustaf Jederström has more than 30 years experience of R&D in the pharmaceutical industry, where he has been instrumental in bringing numerous new pharmaceutical products to market. | Directeur Général | 19/01/2012 |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Ulrika Maria Wennberg
| University of Lund | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Jederstrom Pharmaceuticals AB
Jederstrom Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Jederstrom Pharmaceuticals is a life sciences company that is developing new formulations for oral delivery of therapeutic proteins. These new formulations offer new and improved therapeutic possibilities, cost advantages and the convenience factor of oral administration. The vision of Jederstrom Pharmaceuticals is to make oral administration the method of choice for a number of key therapeutic proteins. Jederstrom Pharmaceuticals initial focus is to develop an insulin formulation for oral administration. Formulations of other well-known therapeutic proteins will then be developed. Jederstrom Pharmaceuticals' business model shall be out licensing. Jederstrom Pharmaceuticals was founded in 2001 by Gustaf Jederström, inventor of the formulation technology. Gustaf Jederström has more than 30 years experience of R&D in the pharmaceutical industry, where he has been instrumental in bringing numerous new pharmaceutical products to market. | Health Technology |
PharmaSurgics In Sweden AB
 PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
DermaGen AB
 DermaGen AB Pharmaceuticals: MajorHealth Technology DermaGen AB develops drugs and medical devices. It focuses on the development of topically applied products for the prevention and treatment of bacterial and fungal skin infections. The company was founded on February 2, 2004 and is headquartered in Solna, Sweden. | Health Technology |
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Health Technology |
Axelar AB
Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Health Technology |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
| Huge Fastigheter AB | |
Södertörns Utvecklingscentrum
Södertörns Utvecklingscentrum Miscellaneous Commercial ServicesCommercial Services Södertörns Utvecklingscentrum is a private company based in Huddinge, Sweden. The Swedish company provides professional services. | Commercial Services |
| Söderenergi Kraftvärme AB | |
SRV Återvinning AB
SRV Återvinning AB SemiconductorsElectronic Technology SRV Återvinning AB is a private company based in Huddinge, SE. SRV Återvinning AB manufactures renewable energy semiconductor products. The Swedish company was founded in 1949. Mette Holst has been the CEO of the company since 2018. | Electronic Technology |
| Södertörns Fjärrvärme AB | |
| Södertörns Energi AB |